BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

  April 16, 2025

   · 

  10 min read
• Press Releases

  Marvel Biosciences to Give Oral Presentation at The Annual IRSF Rett Syndrome Scientific Meeting

  April 16, 2025

   · 

  4 min read
• 

  Mergers & acquisitions

  Bluebird’s Second Suitor, Ayrmid, Fails To Produce an Offer

  Despite making an unsolicited bid for gene therapy maker bluebird bio, Ayrmid failed to deliver a binding offer after weeks of due diligence. Bluebird’s board recommended that it go with Carlyle and SK Capital Partner’s original offer to take the company private for $30 million.

  April 16, 2025

   · 

  1 min read

   · 

  Dan Samorodnitsky
• Press Releases

  Biorem Reports Record Revenues and Earnings before tax for 2024 and Again Reports Record Order Backlog

  April 16, 2025

   · 

  4 min read
• 

  Regulatory

  Former FDA Officials Sound Alarm: Visible Changes May Be ‘Tip of the Iceberg’

  In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER director spoke to analysts about potential implications for drug review timelines and agency morale.

  April 16, 2025

   · 

  3 min read

   · 

  Heather McKenzie
• Press Releases

  Augurex Secures Health Canada Approval for SPINEstat™, a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis

  April 16, 2025

   · 

  1 min read
• Press Releases

  Medline announces FDA clearance for REFLEX® HYBRID Nitinol Implants for foot and ankle surgery

  April 16, 2025

   · 

  3 min read
• Press Releases

  Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

  April 16, 2025

   · 

  7 min read
• Press Releases

  Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US

  April 16, 2025

   · 

  4 min read
• Press Releases

  Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

  April 16, 2025

   · 

  8 min read